Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T79210 |
PIKfyve-IN-2
|
||
PIKfyve-IN-2是PIKfyve激酶高效抑制剂,适用于癌症和自身免疫性疾病的研究领域。 | |||
T33467 |
MOMIPP
|
PI3K | PI3K/Akt/mTOR signaling |
MOMIPP 是一种 PIKfyve 抑制剂,是一种巨胞饮作用的诱导剂,可穿过血脑屏障 (BBB)。 | |||
T2018 |
Apilimod
阿匹莫德,阿吡莫德,STA 5326 |
IL Receptor; PI3K; Interleukin | Immunology/Inflammation; PI3K/Akt/mTOR signaling |
Apilimod (STA 5326) 是一种有效的、高度选择性的PIKfyve 抑制剂,是一种 IL-12/IL-23 的有效抑制剂,抑制人和猴的 PBMC 细胞中的 IL-12,IC50值为 1 nM 和 2 nM。 | |||
T68485 |
Apilimod HCl
|
||
Apilimod dimesylate is a potent and selective PIKfyve inhibitor. It exhibits no significant activity at other lipid kinases and protein kinases, including PIP4K, PIP5K, mTOR, PI3K and PI4K. Apilimod dimesylate inhibits cellular entry by SARS-CoV-2, MERS-CoV and MHV S pseudovirions. It reduces the number of SARS-CoV-2-infected hiPSC-derived pneumocyte-like cells by 85% and inhibits SARS-CoV-2 replication in donor lung tissue. It also exhibits selective cytotoxicity in B-cell non-Hodgkin lymphoma ... |